ProShares Ultra Nasdaq Biotechnology

The index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.

The current price of BIB ETF is 45.20 USD — it has decreased by -0.20% in the past 24 hours. Watch BIB ETF price performance more closely on the advanced chart.

BIB ETF has increased by 8.92% in the past week, has increased by 9.39% in the past month, and has decreased by -21.91% in the past year. See more data on BIB ETF chart.

As of 21 May 2025, the largest holdings include Vertex Pharmaceuticals Inc, Gilead Sciences Inc, Amgen Inc, Regeneron Pharmaceuticals Inc, AstraZeneca PLC ADR, Alnylam Pharmaceuticals Inc. See the full list of BIB ETF holdings.

The BIB ETF consists of 92 holdings, including Vertex Pharmaceuticals Inc, Gilead Sciences Inc, Amgen Inc and others. See the full list of BIB ETF holdings.

As of 21 May 2025, the BIB ETF consists of 92 holdings. See the full list of BIB ETF holdings.

The BIB ETF sectors include Healthcare, Basic Materials, Consumer Cyclical, Financial Services, Real Estate and more.

The easiest way to buy BIB ETF is through an online broker. Some of the popular names are Vanguard, Fidelity, Schwab. Simply open an account, follow the procedures, and start trading. Alternatively, you can practice trading ETFs on Profit.com in Playtrade Tournaments or choose a recommended broker to trade directly.